Restoring the Permanently Lost Foundation Guild™ is Possible.

Notitia's proprietary Foundation Guild™ Microbiome R&D Platform allows us to develop unique and effective treatments for various diseases and complications.

Bacterial Medicine (BM306)

BM306 is a pill that contains the Foundation Guild™ bacteria. This drug is designed to replenish the missing or extinct Foundation Guild™ bacteria in a patient's gut microbiome.

Nutritional Medicine (NM108)

NM108 is a nutrient formula that is designed to promote the growth of either the existing or replenished Foundation Guild™ bacteria in a patient's gut microbiome.

For Expanded Access (compassionate use), please contact us at ExpandedAccess@notitabio.com

Clinical Pipeline

Condition Pre-clinical Phase
1		 Phase
2		 Phase
3
Suspected or Confirmed COVID-19 in type 2 diabetic or prediabetic patients Completed Completed in-progress
Early/End-stage Diabetic Kidney Disease (DKD) Completed Completed
Side-effects of Cancer Chemotherapy Completed Completed
Multiple Sclerosis (MS) Completed Completed
Prader-Willi Syndrome (PWS) Completed
If you are a patient who is interested in joining our ongoing clinical trial, please visit ClinicalTrials.gov for more information.
If you are a physician or patient who is interested in joining our Expanded Access Program (Compassionate Use), please contact us at ExpandedAccess@notitabio.com


For more information on the FDA Expanded Access Program, please visit the official FDA website.